Guevara-Valdivia ME, Iturralde TP, Micheli A, Huarte HY, Galvan L, Colín LL, González-Hermosillo JA

Language: Spanish
References: 6
Page: 45-48
PDF size: 166.92 Kb.

ABSTRACT

We present the case of a woman with familial antecedents of a brother who died suddenly at the age of 39 years, and an other with Brugada syndrome. The ECG had not shown the typical pattern of the Brugada syndrome. Based on these antecedents, we decided to perform a pharmacological test with endovenous propafenone, which revealed the electrocardiographic alterations at 10 min after the administration. This is the first case in our knowledge in which endovenous propafenone manifested a concealed Brugada syndrome.

REFERENCES

1. Brugada P, Brugada R, Brugada J: Sudden death in patients and relatives with the syndrome of right bundle branch block, ST segment elevation in the precordial leads V1 to V3 and sudden death. Eur Heart J 2000; 21: 321-326.

2. Goethals P, Debruyne P, Saffarian M: Drug-induced Brugada syndrome. Acta Cardiol 1998; 53: 157-160.

3. Brugada R, Brugada J, Antzelevitch C, Kirsch GE, Potenzo D, Towbin JA, Brugada P: Sodium Channel Blockers Identify Risk for Sudden Death in Patient With ST-Segment Elevation and Right Bundle Branch Block but Structurally Normal Heart. Circulation 2000; 101: 510-515.

4. Matana A, Goldner V, Stanic K, Mavric Z, Zaputovic L, Matana Z: Unmasking Effect of Propafenone on the Concealed Form of the Brugada Phenomenon. PACE 2000; 23: 416-418.

5. Yasuda M, Nakazato Y, Yamashita H, Sekita G, Kawano Y, Mineda Y et al: ST segment elevation in the right precordial leads following administration of class Ic antiarrhythmic drugs. Heart 2001; 85: e3.

6. Guevara-Valdivia ME, Iturralde Torres P, de Micheli A, Colín Lizalde L, Medeiros Domingo A, González-Hermosillo JA: Alteraciones electrocardiográficas durante el esfuerzo en un paciente con “síndrome de Brugada”. Arch Cardiol Mex 2001; 71: 66-72.